Thor D Stein Selected Research

Chronic Traumatic Encephalopathy

1/2022	MicroRNA Alterations in Chronic Traumatic Encephalopathy and Amyotrophic Lateral Sclerosis.
1/2022	A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease.
1/2022	Association of APOE Genotypes and Chronic Traumatic Encephalopathy.
12/2021	Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer's disease.
10/2021	Validity of the 2014 traumatic encephalopathy syndrome criteria for CTE pathology.
1/2021	A proteomic network approach resolves stage-specific molecular phenotypes in chronic traumatic encephalopathy.
1/2020	Evolution of neuronal and glial tau isoforms in chronic traumatic encephalopathy.
1/2018	Cerebrospinal fluid tau, Aβ, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration.
1/2018	Characterization of Detergent Insoluble Proteome in Chronic Traumatic Encephalopathy.
1/2017	Transcriptome analyses of chronic traumatic encephalopathy show alterations in protein phosphatase expression associated with tauopathy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thor D Stein Research Topics

Disease

26	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 01/2003
15	Chronic Traumatic Encephalopathy 01/2022 - 05/2012
10	Tauopathies 01/2021 - 01/2014
6	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2018 - 05/2012
5	Dementia (Dementias) 08/2022 - 08/2013
5	Cognitive Dysfunction 01/2022 - 01/2014
5	Atrophy 12/2021 - 01/2014
5	Inflammation (Inflammations) 01/2021 - 07/2012
3	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2021 - 01/2013
3	Neuroinflammatory Diseases 11/2018 - 05/2015
3	Wounds and Injuries (Trauma) 12/2016 - 05/2012
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2021 - 01/2014
2	Craniocerebral Trauma (Head Injury) 01/2021 - 01/2020
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 01/2019
2	Gliosis 12/2018 - 01/2018
2	Frontotemporal Dementia (Semantic Dementia) 12/2018 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2018 - 01/2014
1	Breast Neoplasms (Breast Cancer) 06/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022
1	Neurobehavioral Manifestations 10/2021
1	Melanoma (Melanoma, Malignant) 02/2021
1	Neoplasms (Cancer) 02/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Eye Diseases (Eye Disease) 01/2020
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2019
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2019
1	Parkinsonian Disorders (Parkinsonism) 01/2018
1	Classical Lissencephalies and Subcortical Band Heterotopias 01/2018
1	Pneumonia (Pneumonitis) 12/2016
1	Brain Concussion (Cerebral Concussion) 12/2016
1	Hypertension (High Blood Pressure) 01/2014
1	Obesity 01/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2014
1	Stroke (Strokes) 01/2014
1	Headache (Headaches) 01/2013
1	Glioblastoma (Glioblastoma Multiforme) 01/2011

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2003
11	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2003
10	Biomarkers (Surrogate Marker)IBA 10/2022 - 10/2018
7	Apolipoproteins E (ApoE)IBA 11/2022 - 10/2018
7	tau Proteins (tau Protein)IBA 01/2018 - 05/2012
6	Amyloid beta-PeptidesIBA 01/2022 - 09/2004
4	ApolipoproteinsIBA 11/2022 - 10/2018
4	DNA-Binding Proteins (DNA Binding Protein)IBA 05/2015 - 01/2013
2	Complement C4 (Complement Component 4)IBA 11/2022 - 10/2021
2	Protein Isoforms (Isoforms)IBA 12/2021 - 01/2020
2	CytokinesIBA 01/2021 - 01/2018
2	Peptides (Polypeptides)IBA 01/2017 - 07/2015
2	AntioxidantsIBA 01/2014 - 08/2004
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 11/2022
1	Threonine (L-Threonine)FDA Link 10/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	TESIBA 10/2021
1	S100 Proteins (S 100 Protein)IBA 02/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2020
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2020
1	AMPA Receptors (AMPA Receptor)IBA 01/2020
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2020
1	RNA Precursors (Precursor, mRNA)IBA 01/2020
1	Protein Kinase CIBA 01/2020
1	Histones (Histone)IBA 01/2020
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2020
1	InterleukinsIBA 01/2019
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2019
1	Retinaldehyde (Retinal)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Glial Fibrillary Acidic ProteinIBA 12/2018
1	C-Reactive ProteinIBA 10/2018
1	Apolipoprotein E2IBA 10/2018
1	Apolipoprotein E4IBA 10/2018
1	Apolipoprotein E3IBA 10/2018
1	EnzymesIBA 01/2018
1	Cholinergic ReceptorsIBA 01/2018
1	ElementsIBA 01/2018
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2018
1	Carisoprodol (Soma)FDA LinkGeneric 01/2018
1	ProteomeIBA 01/2018
1	Caveolin 1IBA 01/2018
1	Dopa DecarboxylaseIBA 01/2018
1	adenylate cyclase 3IBA 01/2018
1	Detergents (Detergent)IBA 01/2018
1	Chloride Channels (Chloride Channel)IBA 01/2018
1	pramlintide (Symlin)FDA Link 01/2017
1	LigandsIBA 01/2017
1	Islet Amyloid PolypeptideIBA 01/2017
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2017
1	Islet Amyloid Polypeptide ReceptorsIBA 01/2017
1	Substance PIBA 12/2016
1	salicylhydroxamic acid (SHAM)IBA 12/2016
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 12/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016
1	Serine (L-Serine)FDA Link 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	CholesterolIBA 01/2014
1	alpha-SynucleinIBA 01/2013
1	UbiquitinIBA 07/2012

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2011